Taysha Gene Therapies (TSHA) Interest Coverage Ratio (2022 - 2025)
Historic Interest Coverage Ratio for Taysha Gene Therapies (TSHA) over the last 4 years, with Q3 2025 value amounting to 2268.27.
- Taysha Gene Therapies' Interest Coverage Ratio fell 11020.31% to 2268.27 in Q3 2025 from the same period last year, while for Sep 2025 it was 1399.04, marking a year-over-year decrease of 116398.73%. This contributed to the annual value of 896.66 for FY2024, which is 608657.22% down from last year.
- According to the latest figures from Q3 2025, Taysha Gene Therapies' Interest Coverage Ratio is 2268.27, which was down 11020.31% from 1573.71 recorded in Q2 2025.
- Taysha Gene Therapies' Interest Coverage Ratio's 5-year high stood at 11.05 during Q3 2023, with a 5-year trough of 2268.27 in Q3 2025.
- Moreover, its 4-year median value for Interest Coverage Ratio was 73.89 (2022), whereas its average is 588.55.
- As far as peak fluctuations go, Taysha Gene Therapies' Interest Coverage Ratio skyrocketed by 8368.87% in 2023, and later tumbled by 966819.44% in 2024.
- Taysha Gene Therapies' Interest Coverage Ratio (Quarter) stood at 41.35 in 2022, then skyrocketed by 44.9% to 22.79 in 2023, then plummeted by 3876.23% to 906.0 in 2024, then plummeted by 150.36% to 2268.27 in 2025.
- Its last three reported values are 2268.27 in Q3 2025, 1573.71 for Q2 2025, and 1127.42 during Q1 2025.